海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- Clinical Trial Testing the efficacy and Safety of Two Ramucirumab Doses Given as Second Line Treatment to Patients with Stomach Cancer
- Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma MedDRA version: 20.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Czech Republic, Germany, Greece, Spain, Sweden, Turkey, Ukraine, United States
- 2015-06-09
Not recruiting
- Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients
- Multiple Myeloma
- France, Germany
- 2015-05-21
Not recruiting
- Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
- Hyperparathyroidism
- France
- 2015-04-29
Not Recruiting
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
- Kidney Transplantation # Chronic Kidney Failure;N18 - Chronic kidney disease
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Mexico, Poland, South Africa, Spain, Sweden, Switzerland, Turkey, United States
- 2015-04-14
Not Recruiting
- A clinical trial demonstrating the safety and efficacy of treatment of lines between the eye brows with the test drug DWP-450 in adults by comparison with Botox and Placebo.
- moderate-to-severe glabellar lines br>MedDRA version: 17.1 Level: LLT Classification code 10052609 Term: Glabellar frown lines System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, France, Germany, Sweden, United Kingdom
- 2015-03-20
Not recruiting
- Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy
- Breast Neoplasms
- Spain
- 2015-03-19
Not recruiting
- A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
- Recurrent Head and Neck Cancer;Metastatic Head and Neck Cancer
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2015-02-03
Not recruiting
- Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®
- Glabellar Lines
- Australia, Brazil, Czech Republic, Kazakhstan, Lebanon, Russian Federation, Turkey, Ukraine
- 2015-01-29
Not Recruiting
- This study will aim to assess the safety and how effective the next generation of BTX-AHAC (BTX-A-HAC NG) with an injectable liquid formulation is for improving the appearance of lines (wrinkles) between the eyebrows (glabellar area) after repeated treatment.
- Moderate to severe Glabellar lines br>MedDRA version: 19.0 Level: LLT Classification code 10052609 Term: Glabellar frown lines System Organ Class: 100000004858 ;Therapeutic area: Body processes [G] - Physical Phenomena [G01]
- France, Germany, United Kingdom
- 2014-12-23
Not Recruiting
- A multicenter, randomized, double blind, parallel group, vehicle controlled, study of the safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 8 weeks in pediatric subjects (2 to 12 years of age) with mild to moderate plaque psoriasis
- Psoriasis;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Belgium, Canada, Germany, Hungary, Italy, Spain, United States
- 2014-10-28
Not recruiting
- Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
- Germline BRCA1/2 Mutations and;Metastatic Adenocarcinoma of the Pancreas
- Australia, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom, United States
- 2014-06-06
Not recruiting
- Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET
- Prostate Cancer
- Australia, Canada, Ireland, New Zealand, United Kingdom, United States of America
- 2014-01-29
Not recruiting
- A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection
- Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics
- Australia, Canada, France, Germany, Italy, New Zealand, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2013-09-06
Not recruiting
- Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
- Newly Diagnosed;Advanced Ovarian Cancer;FIGO Stage III-IV;BRCA Mutation;Complete Response;Partial Response;First Line Platinum Chemotherapy
- Australia, Brazil, Canada, China, France, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, United Kingdom, United States
- 2013-04-30
Not Recruiting
- Phase 1 clinical study to assess safety of single infusions of rADAMTS13 (BAX930) in humans and to evaluate distribution and elimination of rADAMTS13 (BAX930) from the human body after administration at 3 different dose levels in patients diagnosed with severe hereditary TTP
- Subjects diagnosed with hereditary thrombotic thrombocytopenic purpura (TTP) MedDRA version: 18.0 Level: LLT Classification code 10043562 Term: Thrombocytopenic purpura, thrombotic System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Germany, Japan, Poland, United Kingdom, United States
- 2012-11-12
Not Recruiting
- A clinical trial intended to assess the Efficacy and Safety of MYL-1402O Compared With Avastin®, in the First-line Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer
- Non-Squamous Non-Small Cell Lung Cancer
- Argentina, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, Croatia, Georgia, Hungary, India, Indonesia, Italy, Malaysia, Philippines, Poland, Romania, Russian Federation, Spain, Taiwan, Turkey, Ukraine, Viet Nam
- 2016-12-09
Not recruiting
- A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin Depressions
- Cheek Line Depressions;Cheek Line Depressions;Cheek Line Depressions;Cheek Line Depressions
- France
- 2016-11-30
Not recruiting
- The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line
- Essential Thrombocythemia
- France
- 2016-10-05
Not recruiting
- First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments
- Atrial Fibrillation
- France
- 2016-08-26
Not recruiting
- Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
- Carcinoma, Squamous Cell
- France
- 2016-08-25